GlassScriptPhysician profile
Yury Gadayev
NPI 1841371796
$18,063.03
in general payments reported to CMS, 2019-2025
65 companies · $4,191 in 2025
The $4,191 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,700 · 2022: $3,688 · 2023: $2,539 · 2024: $2,945 · 2025: $4,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,562 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,561.63 |
| Education | $113.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,848.74 | 2021-2025 | |
| Pfizer INC. | $1,304.90 | 2021-2025 | |
| Genzyme Corporation | $1,101.52 | 2021-2025 | |
| Argenx US, INC. | $901.95 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Neurocrine Biosciences, INC. | $788.66 | 2021-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $751.73 | 2021-2025 | Kisunla, Amyvid, Emgality |
| Biogen, INC. | $715.46 | 2021-2023 | Vumerity, Tysabri |
| Novartis Pharmaceuticals Corporation | $710.04 | 2021-2024 | |
| Emd Serono, INC. | $658.05 | 2021-2025 | Mavenclad |
| Lundbeck LLC | $621.52 | 2021-2025 | Vyepti, Rexulti |
| Biohaven Pharmaceuticals, INC. | $502.07 | 2021 | |
| Amgen INC. | $494.29 | 2021-2025 | Aimovig, Tezspire |
| Eisai INC. | $445.63 | 2021-2025 | |
| Ucb, INC. | $376.27 | 2021-2025 | Fintepla, Nayzilam, Briviact |
| Takeda Pharmaceuticals U.S.A., INC. | $373.52 | 2023-2025 | Takhzyro, Hyqvia, Glassia |
Show all 65 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $364.62 | 2022-2025 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $358.25 | 2021-2025 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $353.81 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Neurelis, INC. | $328.33 | 2021-2025 | Valtoco |
| Supernus Pharmaceuticals, INC. | $298.62 | 2021-2022 | |
| Csl Behring | $288.20 | 2021-2025 | Hizentra, Andembry |
| Cycle Pharmaceuticals INC | $281.17 | 2024-2025 | Sajazir, Tascenso Odt, Ormalvi |
| Genentech USA, INC. | $250.47 | 2021-2024 | Ocrevus, Ocrevus Zunovo |
| Biohaven Pharmaceutical Holding Company LTD. | $250.18 | 2022 | |
| Sk Life Science, INC. | $241.28 | 2021-2025 | Xcopri |
| Allergan, INC. | $240.95 | 2021-2022 | |
| Grifols USA, LLC | $234.82 | 2021-2025 | Gamunex-C, Xembify, Prolastin-C Liquid |
| Octapharma USA, INC. | $226.42 | 2022-2023 | Panzyga |
| Mallinckrodt Hospital Products INC. | $209.79 | 2021-2025 | Acthar |
| Janssen Biotech, INC. | $170.43 | 2025 | |
| Boston Scientific Corporation | $164.58 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $153.24 | 2023-2025 | Tezspire, Flumist Quadrivalent, Airsupra |
| Merz Pharmaceuticals, LLC | $152.53 | 2021-2025 | Xeomin, Inbrija |
| Amneal Pharmaceuticals LLC | $151.56 | 2021-2022 | |
| Livanova USA, INC. | $149.77 | 2022-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Axsome Therapeutics, INC. | $138.56 | 2025 | Symbravo |
| Avanir Pharmaceuticals, INC. | $135.02 | 2021-2022 | |
| Pharming Healthcare, INC. | $125.00 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $121.33 | 2023-2024 | Nuedexta |
| Tg Therapeutics, INC. | $99.58 | 2023 | |
| Janssen Pharmaceuticals, INC | $82.64 | 2021-2025 | |
| Celgene Corporation | $80.04 | 2022-2023 | Zeposia |
| Banner Life Sciences, LLC | $77.41 | 2021-2023 | |
| Sobi, INC | $74.87 | 2024 | |
| Xeris Pharmaceuticals, INC. | $57.85 | 2024-2025 | Keveyis |
| Kyowa Kirin, INC. | $51.45 | 2021-2023 | Nourianz |
| Sunovion Pharmaceuticals INC. | $49.62 | 2021 | |
| X4 Pharmaceuticals, INC. | $47.70 | 2025 | Xolremdi |
| Upsher-Smith Laboratories LLC | $47.62 | 2021-2022 | |
| Averitas Pharma INC. | $39.82 | 2024 | Qutenza |
| Acorda Therapeutics, INC | $39.51 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $35.20 | 2024 | |
| Scilex Pharmaceuticals INC. | $30.13 | 2024-2025 | |
| Mdd US Operations, LLC | $29.95 | 2021-2023 | Gocovri |
| Kedrion Biopharma INC. | $27.74 | 2021 | |
| Abbott Laboratories | $27.19 | 2022 | |
| Nevro Corp. | $27.09 | 2022 | |
| Sumitomo Pharma America, INC. | $26.57 | 2023 | Aptiom |
| Aurinia Pharma U.S., INC. | $22.65 | 2024 | Lupkynis |
| Idorsia Pharmaceuticals US INC | $20.59 | 2023 | Quviviq |
| Collegium Pharmaceutical, INC. | $19.62 | 2022 | |
| Impel Pharmaceuticals INC. | $18.82 | 2023 | Trudhesa |
| Tanabe Pharma America, INC. | $18.24 | 2021 | |
| Bio Products Laboratory USA, INC. | $16.08 | 2023 | Coagadex, Gammaplex |
| Kedrion Biopharma, INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yury Gadayev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.